American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients

Simple item page
dc.contributor.authorJuan Esteban Gómez‐Mesa
dc.contributor.authorJuliana María Gutiérrez‐Posso
dc.contributor.authorManuela Escalante‐Forero
dc.contributor.authorBrayan Daniel Córdoba‐Melo
dc.contributor.authorPaula Andrea Cárdenas‐Marín
dc.contributor.authorEduardo Perna
dc.contributor.authorMádelyn Raquel Valle‐Ramos
dc.contributor.authorGermán Camilo Giraldo
dc.contributor.authorNoel A. Flórez-Alarcón
dc.contributor.authorIda Fabiola Rodríguez Caballero
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:21:32Z
dc.date.available2026-03-22T14:21:32Z
dc.date.issued2023
dc.descriptionCitaciones: 10
dc.description.abstractAMERICCAASS is the first continental registry to include hospitalized or outpatient patients with HF. Regarding optimal medical therapy, approximately a quarter of the patients still need to receive BB and ACEI/ARB/ARNI, less than half do not receive MRA, and more than two-thirds do not receive SGLT2i.
dc.identifier.doi10.1002/clc.24182
dc.identifier.urihttps://doi.org/10.1002/clc.24182
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/46047
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofClinical Cardiology
dc.sourceIcesi University
dc.subjectMedicine
dc.subjectHeart failure
dc.subjectInterquartile range
dc.subjectInternal medicine
dc.subjectDecompensation
dc.subjectAmbulatory
dc.subjectSpironolactone
dc.subjectCardiology
dc.titleAmerican Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients
dc.typearticle

Files

Collections

Artículo Científico Publicado